-
Published27/12/2024
-
Deadline27/01/2025
-
Opening of tenders27/01/2025
-
Today15/03/2025
Utilities
- indicates text translated automatically in your browsing language
Open tender procedure for the supply of medicines under the drug programme Aflibercept, Farycymab, Bevacizumab, Ranibizumab and Dexamethazone Text automatically translated in your browsing language Automatically translated
The subject-matter of the contract is the supply of medicines under the Aflibercept, Farycymab, Bevacizumab, Ranibizumab and Dexamethazone medicines programme in the quantities and parameters set out in Annexes 1.1 to 1.5 to the tender specifications. Text automatically translated in your browsing language Automatically translated
https://platformazakupowa.pl/pn/szpitalmiejski_elblag
https://platformazakupowa.pl/pn/szpitalmiejski_elblag
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.